Archive | December, 2012

India’s new drug pricing policy : will data be the stumbling block?

13 Dec

On December 7, India’s National Pharmaceutical Pricing Policy 2012 was finally tabled in Parliament. Assuming that this policy does get rolled out irrespective of a Supreme Court hearing on drug pricing playing out in parallel, the cornerstone of the policy may create some vexing issues. Continue reading

India & drug pricing : Can key word in policy influence impact?

4 Dec

Could a single word in the new drug pricing policy mitigate the extent of its impact on the pharma industry’s profitability or is this mere wishful thinking?  A senior industry source claimed to Apothecurry that the choice of Continue reading

%d bloggers like this: